companies
>
S
> Sanofi-Aventis
Sanofi-Aventis
Sanofi-Aventis expands Regeneron research deal to $1 billion
11 November 2009
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
Sanofi-Aventis to acquire Merck's Merial stake for $4 billion
30 July 2009
Sanofi-Aventis to acquire Shantha Biotech for Rs3,757 crore
27 July 2009
Sanofi’s diabetes drug may increase cancer risk: European study
27 June 2009
Sanofi-Aventis inks cancer drug research deal with Exelixis
29 May 2009
Sanofi to buy US cancer drug firm for about $500 million
15 April 2009
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
PPF ends opposition to Zentiva sale; Sanofi takeover likely
11 February 2009
Sanofi settles Allegra, Nasacort patent suits with Teva, Barr
20 November 2008
French pharma Sanofi-Aventis acquires Zentiva for $2.6 billion
23 September 2008
Sanofi-aventis to acquire Symbion Holdings for $544 million
21 July 2008
Zentiva turns down PPF subsidiary Anthiarose as Sanofi makes rival bid
23 June 2008
Top two shareholders, including Sanofi-Aventis, launch competing bids for Czech drugmaker Zentiva
19 June 2008
Sanofi commits 60 million doses of H5N1 vaccine for WHO global H5N1 vaccine stockpile
16 June 2008
French drug giant Sanofi-Aventis opens R&D centre in Goa
05 December 2007
Dr Reddy's in discussions with Sanofi-Aventis to settle Plavix litigation
22 March 2006
search domain-b
go
Legal Policy | Copyright
©
1999-2009 The Information Company Private Limited. All rights reserved.
